US Stock MarketDetailed Quotes

ACHL Achilles Therapeutics

Watchlist
  • 0.890
  • -0.050-5.35%
Close May 13 16:00 ET
36.56MMarket Cap-556P/E (TTM)

Achilles Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.95%-17.51M
18.62%-48.45M
26.64%-14.19M
13.48%-17.85M
-0.42%-59.54M
-19.34M
65.38%-3.15M
12.14%-16.41M
-19.81%-20.64M
-134.77%-59.28M
Net income from continuing operations
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-0.87%-17.51M
-16.49%-71.18M
---24.06M
3.65%-12.48M
-7.01%-17.29M
-26.08%-17.36M
-84.04%-61.1M
Operating gains losses
233.33%4K
-107.50%-3K
-89.47%2K
50.00%-3K
-74.84%40K
--19K
---19K
--46K
---6K
--159K
Depreciation and amortization
6.50%1.18M
27.72%4.71M
38.15%1.15M
5.22%1.11M
12.23%3.69M
--831K
6.97%890K
10.36%916K
33.46%1.05M
325.91%3.29M
Other non cash items
104.92%6K
54.08%-276K
-50.68%-110K
67.03%-122K
-3,238.89%-601K
---73K
76.27%-70K
22.12%-88K
-170.21%-370K
-101.53%-18K
Change In working capital
-160.44%-7.81M
274.76%10.41M
142.37%2.01M
49.32%-3M
24.90%-5.96M
---4.73M
337.25%6.89M
52.95%-2.2M
3.91%-5.92M
-364.01%-7.93M
-Change in prepaid assets
-71.94%-5.15M
247.68%10.11M
165.65%1.87M
26.04%-3M
29.95%-6.85M
---2.85M
41.17%6.08M
37.83%-6.02M
-66.82%-4.05M
-213.17%-9.77M
-Change in payables and accrued expense
-40,428.57%-2.82M
-177.75%-870K
47.17%-915K
100.43%7K
-52.54%1.12M
---1.73M
123.60%593K
-23.77%3.89M
54.97%-1.63M
-71.62%2.36M
-Change in other current assets
123.29%17K
384.36%927K
1,377.94%869K
68.53%-73K
39.96%-326K
---68K
119.72%43K
26.60%-69K
-123.08%-232K
80.58%-543K
-Change in other current liabilities
--151K
-89.72%33K
-77.40%33K
--0
582.98%321K
--146K
----
----
----
-92.35%47K
-Change in other working capital
----
193.33%210K
--145K
--65K
-922.73%-225K
----
----
----
----
-450.00%-22K
Cash from discontinued investing activities
Operating cash flow
1.95%-17.51M
18.62%-48.45M
26.64%-14.19M
13.48%-17.85M
-0.42%-59.54M
---19.34M
65.38%-3.15M
12.14%-16.41M
-19.81%-20.64M
-134.77%-59.28M
Investing cash flow
Cash flow from continuing investing activities
-53.08%-695K
85.36%-1.1M
97.72%-46K
75.62%-454K
1.60%-7.51M
-2.02M
-55.78%-1.9M
14.78%-1.74M
21.63%-1.86M
35.56%-7.63M
Net PPE purchase and sale
-53.08%-695K
85.36%-1.1M
97.72%-46K
75.62%-454K
1.60%-7.51M
---2.02M
-55.78%-1.9M
14.78%-1.74M
21.63%-1.86M
35.56%-7.63M
Cash from discontinued investing activities
Investing cash flow
-53.08%-695K
85.36%-1.1M
97.72%-46K
75.62%-454K
1.60%-7.51M
---2.02M
-55.78%-1.9M
14.78%-1.74M
21.63%-1.86M
35.56%-7.63M
Financing cash flow
Cash flow from continuing financing activities
400.00%5K
800.00%9K
0
1K
-100.00%1K
0
-98.33%1K
0
0
41.38%160.76M
Net common stock issuance
----
800.00%9K
----
----
--1K
----
----
----
----
--0
Net preferred stock issuance
----
--0
----
----
--0
----
----
----
----
--0
Proceeds from stock option exercised by employees
400.00%5K
--0
-800.00%-9K
--1K
--0
---1K
----
----
----
--160.76M
Cash from discontinued financing activities
Financing cash flow
400.00%5K
800.00%9K
--0
--1K
-100.00%1K
--0
-98.33%1K
--0
--0
41.38%160.76M
Net cash flow
Beginning cash position
-24.11%131.57M
-34.91%173.37M
-22.09%140.17M
-34.91%173.37M
49.76%266.35M
--179.92M
-32.64%201.63M
48.79%236.96M
49.76%266.35M
82.23%177.85M
Current changes in cash
0.61%-18.2M
26.11%-49.54M
33.35%-14.24M
18.63%-18.31M
-171.45%-67.05M
---21.36M
50.78%-5.05M
-112.88%-18.14M
-9.67%-22.5M
22.49%93.84M
Effect of exchange rate changes
-129.81%-1.02M
129.85%7.74M
-61.93%5.64M
149.75%3.43M
-386.22%-25.94M
--14.81M
-132.90%-16.66M
-1,941.81%-17.19M
-457.79%-6.89M
-246.14%-5.33M
End cash Position
-29.11%112.36M
-24.11%131.57M
-24.11%131.57M
-33.12%158.49M
-34.91%173.37M
--173.37M
-36.18%179.92M
-32.64%201.63M
48.79%236.96M
49.76%266.35M
Free cash flow
0.58%-18.2M
26.10%-49.55M
33.35%-14.24M
18.62%-18.31M
-0.19%-67.05M
---21.36M
51.06%-5.05M
12.40%-18.14M
-14.79%-22.5M
-80.38%-66.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.95%-17.51M18.62%-48.45M26.64%-14.19M13.48%-17.85M-0.42%-59.54M-19.34M65.38%-3.15M12.14%-16.41M-19.81%-20.64M-134.77%-59.28M
Net income from continuing operations 29.89%-12.27M2.12%-69.67M22.56%-18.63M-0.87%-17.51M-16.49%-71.18M---24.06M3.65%-12.48M-7.01%-17.29M-26.08%-17.36M-84.04%-61.1M
Operating gains losses 233.33%4K-107.50%-3K-89.47%2K50.00%-3K-74.84%40K--19K---19K--46K---6K--159K
Depreciation and amortization 6.50%1.18M27.72%4.71M38.15%1.15M5.22%1.11M12.23%3.69M--831K6.97%890K10.36%916K33.46%1.05M325.91%3.29M
Other non cash items 104.92%6K54.08%-276K-50.68%-110K67.03%-122K-3,238.89%-601K---73K76.27%-70K22.12%-88K-170.21%-370K-101.53%-18K
Change In working capital -160.44%-7.81M274.76%10.41M142.37%2.01M49.32%-3M24.90%-5.96M---4.73M337.25%6.89M52.95%-2.2M3.91%-5.92M-364.01%-7.93M
-Change in prepaid assets -71.94%-5.15M247.68%10.11M165.65%1.87M26.04%-3M29.95%-6.85M---2.85M41.17%6.08M37.83%-6.02M-66.82%-4.05M-213.17%-9.77M
-Change in payables and accrued expense -40,428.57%-2.82M-177.75%-870K47.17%-915K100.43%7K-52.54%1.12M---1.73M123.60%593K-23.77%3.89M54.97%-1.63M-71.62%2.36M
-Change in other current assets 123.29%17K384.36%927K1,377.94%869K68.53%-73K39.96%-326K---68K119.72%43K26.60%-69K-123.08%-232K80.58%-543K
-Change in other current liabilities --151K-89.72%33K-77.40%33K--0582.98%321K--146K-------------92.35%47K
-Change in other working capital ----193.33%210K--145K--65K-922.73%-225K-----------------450.00%-22K
Cash from discontinued investing activities
Operating cash flow 1.95%-17.51M18.62%-48.45M26.64%-14.19M13.48%-17.85M-0.42%-59.54M---19.34M65.38%-3.15M12.14%-16.41M-19.81%-20.64M-134.77%-59.28M
Investing cash flow
Cash flow from continuing investing activities -53.08%-695K85.36%-1.1M97.72%-46K75.62%-454K1.60%-7.51M-2.02M-55.78%-1.9M14.78%-1.74M21.63%-1.86M35.56%-7.63M
Net PPE purchase and sale -53.08%-695K85.36%-1.1M97.72%-46K75.62%-454K1.60%-7.51M---2.02M-55.78%-1.9M14.78%-1.74M21.63%-1.86M35.56%-7.63M
Cash from discontinued investing activities
Investing cash flow -53.08%-695K85.36%-1.1M97.72%-46K75.62%-454K1.60%-7.51M---2.02M-55.78%-1.9M14.78%-1.74M21.63%-1.86M35.56%-7.63M
Financing cash flow
Cash flow from continuing financing activities 400.00%5K800.00%9K01K-100.00%1K0-98.33%1K0041.38%160.76M
Net common stock issuance ----800.00%9K----------1K------------------0
Net preferred stock issuance ------0----------0------------------0
Proceeds from stock option exercised by employees 400.00%5K--0-800.00%-9K--1K--0---1K--------------160.76M
Cash from discontinued financing activities
Financing cash flow 400.00%5K800.00%9K--0--1K-100.00%1K--0-98.33%1K--0--041.38%160.76M
Net cash flow
Beginning cash position -24.11%131.57M-34.91%173.37M-22.09%140.17M-34.91%173.37M49.76%266.35M--179.92M-32.64%201.63M48.79%236.96M49.76%266.35M82.23%177.85M
Current changes in cash 0.61%-18.2M26.11%-49.54M33.35%-14.24M18.63%-18.31M-171.45%-67.05M---21.36M50.78%-5.05M-112.88%-18.14M-9.67%-22.5M22.49%93.84M
Effect of exchange rate changes -129.81%-1.02M129.85%7.74M-61.93%5.64M149.75%3.43M-386.22%-25.94M--14.81M-132.90%-16.66M-1,941.81%-17.19M-457.79%-6.89M-246.14%-5.33M
End cash Position -29.11%112.36M-24.11%131.57M-24.11%131.57M-33.12%158.49M-34.91%173.37M--173.37M-36.18%179.92M-32.64%201.63M48.79%236.96M49.76%266.35M
Free cash flow 0.58%-18.2M26.10%-49.55M33.35%-14.24M18.62%-18.31M-0.19%-67.05M---21.36M51.06%-5.05M12.40%-18.14M-14.79%-22.5M-80.38%-66.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----Unqualified Opinion--------Unqualified Opinion

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg